Ionis Pharmaceuticals, Inc.

Email address and contacts

Ionis Pharmaceuticals, Inc. company description

For more than 30 years, Ionis has been the leader in RNA-targeted therapy, pioneering new markets and changing standards of care with its novel antisense technology. Ionis currently has three marketed medicines and a premier late-stage pipeline highlighted by industry-leading cardiovascular and neurological franchises. Our scientific innovation began and continues with the knowledge that sick people depend on us, which fuels our vision of becoming a leading, fully integrated biotechnology company. Our drug discovery platform has served as a springboard for actionable promise and realized hope for patients with unmet needs. We created the first and only approved treatment for children and adults with spinal muscular atrophy as well as the world's first RNA-targeted therapeutic approved for the treatment of polyneuropathy in adults with hereditary transthyretin amyloidosis. To learn more about Ionis follow us on twitter @ionispharma or visit Akcea Therapeutics is a wholly owned subsidiary of Ionis. Akcea commercializes TEGSEDI® and WAYLIVRA®. For more information about Akcea, visit: Spinraza is marketed by Biogen. Ionis is proud to be recognized by the San Diego Business Journal as one of the 2020 Best Places to Work in San Diego. If you think you would be a good fit for our team, please visit the Jobs tab and apply. Learn more about our history: Attention Potential Applicants! Please be aware of employment scams using Ionis’ name and the names of Ionis employees to lure unsuspecting people into providing highly confidential and personal information. For more information visit: See our community guidelines:

Key Employees

Clinical Trial Manager
Find Email
Ian Huggins
Assistant Director, Medicinal Chemistry
Yuya Ogawa
Assistant Director
Yvette Holmes Mba
Associate Director, Global Project & Portfolio Management
Eric Schniepp
Research Associate
Jennifer Westling
Assistant Director, Payroll
Grant Bryce
VP Legal and GC
Sign up to open these and 5 more emails in Ionis Pharmaceuticals, Inc.
Message error line

Ionis Pharmaceuticals, Inc. competitors and alternatives

947 employees
Celltrion Inc.
922 employees
BPL Plasma
880 employees
Spinco Biotech
760 employees
Adaptive Biotechnologies Corp.
757 employees
Oxford Nanopore Technologies
747 employees
View all competitors

Recently updated team members of Ionis Pharmaceuticals, Inc.

Eric Mehigan
Senior Finance Manager of Consolidation & Reporting
Onaiza Jilani Cadoret Manier
EVP, Chief Corporate Development Officer
Frank Rigo
Vice President, Functional Genomics & Drug Discovery
Charles G, Asare, MPH
Vice President, Head of Drug Safety
Linda Wilkes
Drug Safety Manager
Kyle Jenne
EVP, Chief Commercial Officer
View all employees

GetProspect Email Finder

Retrieve thousands of email addresses in single click without leaving your current tab. Download for free now!

100 Free emails every month

Add to Chrome

400+ reviews 50,000+ users

Ready to get started?

Try GetProspect email finder for free, and explore all the tools you need to scale your business

Real data
No credit card needed
Leave any time
Find Emails